News and Stories About PanCAN grantee
Large-scale Molecular Profiling Reveals Clues About Pancreatic Tumors and Cysts
The largest-ever molecular analysis of pancreatic cancer tissue samples – from more than 3,500 patients – revealed some new clues […]
READ MORE
How Pancreatic Cancer Cells Target the Liver
New donor-funded research published today in the journal Nature describes signals that prepare the liver in advance for pancreatic cancer […]
READ MORE
Grantee Tries to Stop Cells Turning into Cancer
Even before certain cells of the pancreas become cancer, changes occur in their ability to break down nutrients, according to […]
READ MORE
It Starts with Someone: Drs. Michael Curran and Randy Pausch
Editor’s note: On July 25, 2008, 10 years ago today, professor Randy Pausch, PhD, of “The Last Lecture” fame, died […]
READ MORE
Meet Our 2018 Research Grantees: Translational Awards
This year, the Pancreatic Cancer Action Network (PanCAN) awarded eight prestigious research grants to scientists and clinicians in the United […]
READ MORE
Meet Our 2018 Research Grantees: Early Career Awards
The Pancreatic Cancer Action Network (PanCAN) recently announced this year’s recipients of prestigious research grants. Funding decisions were made by […]
READ MORE
PanCAN’s Research Grants Program Funds Eight New Projects
The Pancreatic Cancer Action Network (PanCAN) announces the funding of eight new, innovative pancreatic cancer research projects through its Research […]
READ MORE
Institution’s Molecular Profiling Results Affect Clinical Decisions
Every pancreatic tumor is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends molecular profiling of your tumor to help […]
READ MORE
A Grantee’s Long Road ‘Home’ to Research
If you had asked Jason Doles, PhD, five years ago where he anticipated he’d be today, he would not have […]
READ MORE
More than 20,000 Cancer Researchers Converge at International Meeting
The theme for this year’s American Association for Cancer Research (AACR) Annual Meeting, which took place earlier this week in […]
READ MORE
Grantee Discusses Immunotherapy in Smithsonian Magazine
Pancreatic Cancer Action Network (PanCAN) grantee Dung Le, MD, provided commentary in the April 2018 issue of Smithsonian Magazine. The […]
READ MORE
Grantee’s Study Suggests Bacteria Can Influence Tumor Growth and Immune Response
Scientists have known for quite some time that pancreatic tumors are surrounded by an especially dense and complex “stroma,” a […]
READ MORE
NPR Focuses on One of the Biggest Challenges in Pancreatic Cancer: KRAS
About 95 percent of pancreatic cancer cases – and around 30 percent of all human cancers – have a mutation […]
READ MORE
Love at First Lab Meeting
Both Wantong Yao, MD, PhD, and Haoqiang Ying, MD, PhD, underwent medical training in China. They both became deeply interested […]
READ MORE
Grantee Named NYU’s New Director of GI Cancer Research
Paul E. Oberstein, MD, joins NYU Langone Health and its Perlmutter Cancer Center on March 1 as director of gastrointestinal […]
READ MORE
Grantee’s Work Explains Stress in Disease Progression
Two-time Pancreatic Cancer Action Network (PanCAN) research grant recipient, Timothy Wang, MD, set out to answer an unusual question: How […]
READ MORE
2017 Year in Review: Progress in Research, Part 2
Editor’s note: Welcome to the second part of our 2017 research highlights recap (we’re pretty excited that it’s taking two […]
READ MORE
2017 Year in Review: Progress in Research, Part 1
Editor’s note: This article is the first in our “Year in Review” series recapping the year’s top stories in pancreatic […]
READ MORE
In Memoriam: Kenneth Scott, PhD
Pancreatic cancer researcher Kenneth Scott, PhD, associate professor of molecular and human genetics at Baylor College of Medicine, passed away […]
READ MORE
Research Team’s Work Provides Clues that Explain Long-term Survival
A multi-institutional research team, including Vinod Balachandran, MD, and Steven Leach, MD, set out to ask an important question: “What […]
READ MORE
Tumor’s Genetic Changes Can Impact Patient Outcomes
Among the many genetic mutations and molecular alterations that can be found in pancreatic tumors, there are four that are […]
READ MORE
iHeart Radio Features Julie Fleshman on Oct. 15
This Sunday, Oct. 15, tune-in to iHeart Radio Dallas’ “Sunday Morning Magazine” public affairs show featuring Pancreatic Cancer Action Network […]
READ MORE
Grantee Describes New Test to Characterize Pancreatic Cysts
In a forward-looking study of patients diagnosed with various types of cysts of the pancreas, researchers at the University of […]
READ MORE
Study Identifies Surprising Culprit for Chemotherapy Resistance: Bacteria
Sometimes the most unexpected and unusual observations in the laboratory can lead to important results. Such was the case when […]
READ MORE
Nanotechnology Approach to Imaging for Early Detection
Back when he was a postdoctoral researcher, grantee Kazuki Sugahara, MD, PhD, found that a peptide, or small piece of […]
READ MORE
Annual Scientific Meeting Gathers Key Pancreatic Cancer Research Stakeholders
“This is a meeting like no other – and this is an organization like no other!” Thus began the Pancreatic […]
READ MORE
New Findings Explain How Immune Cells Support Pancreatic Tumors
A Pancreatic Cancer Action Network Career Development Award in 2014 allowed David DeNardo, PhD, to ask and answer important questions […]
READ MORE
It Starts with Someone, Channing Der and Marisa Jung
It’s not every day that you get to hear from a Pancreatic Cancer Action Network research grantee and a Pancreatic […]
READ MORE
Nationwide Effort Uncovers Genetic Clues in Pancreatic Cancer Cells
The cleverly named The Cancer Genome Atlas project – abbreviated TCGA, in homage to the four base pairs that make […]
READ MORE
Grantee’s Study Offers Explanation, Potential Treatment Strategy for Obesity-Associated Pancreatic Cancer
When Nada Kalaany, PhD, set out to establish an independent lab at Boston Children’s Hospital, she was determined to answer […]
READ MORE
Breakthrough Study by Pancreatic Cancer Action Network Grantee Evaluates Tumor Growth In Obese Vs. Lean Mice
Breakthrough Study by Pancreatic Cancer Action Network Grantee Evaluates Tumor Growth In Obese Vs. Lean Mice Gene Responsible for Enhanced […]
READ MORE
PanCAN-funded Research Highlighted in Nebraska Media
Researchers at the University of Nebraska Medical Center (UNMC) are making headlines and spreading hope thanks to their findings published […]
READ MORE
Research Grantees and Pancreatic Cancer Survivor Featured in Interview
2017 Grant Recipients and Pancreatic Cancer Survivor Featured on KATU-TV in Portland, Ore. Last month, our organization awarded 17 grants […]
READ MORE
Tiny Balls of Pancreatic Cancer Cells Teach Researchers About Metastasis
One of the biggest challenges faced by scientists trying to solve lingering mysteries about the biology of pancreatic cancer is […]
READ MORE
Stay Informed About Vital Pancreatic Cancer News and Research
Did you read about The New York Times article featuring breakthrough gene therapy and its potential applications to pancreatic cancer? […]
READ MORE
2017 Grant Recipient and Pancreatic Cancer Survivor Featured on WKRC-TV in Cincinnati, Ohio
Earlier this month, our organization awarded 17 grants to 21 researchers at 12 institutions across the country through our competitive […]
READ MORE
Grantees Collaborate to Understand Treatment Resistance
The chemotherapy gemcitabine is widely used to treat pancreatic cancer patients. However, many patients develop resistance to the drug, leading […]
READ MORE
Finding a Secret Passage through Stroma
How can treatments break through the stroma? The complex and dense “stroma” surrounding pancreatic cancer cells has been a major […]
READ MORE
“Stopping the Start” of Pancreatic Cancer
What cells actually become pancreatic cancer? To help answer this question, the Pancreatic Cancer Action Network awarded Jennifer Bailey, PhD, […]
READ MORE
The Road to Effective Immunotherapy for Pancreatic Cancer Patients
Last week, we shared the exciting news that an immunotherapy agent, Keytruda, was the first drug approved by the FDA […]
READ MORE
Cyst Juice to Predict Cancer Risk
Finding out that you have a cyst on your pancreas is a terrifying moment of uncertainty. What are the chances […]
READ MORE
Oral Bacteria Increasing Pancreatic Cancer Risk
While missing teeth and poor dental health were previously believed to be associated with an increased risk of pancreatic cancer, […]
READ MORE
It Starts with Someone: Florencia McAllister
Editor’s note: This story was originally published in 2016, but we are sharing it again this month in celebration and […]
READ MORE
Dallas-Fort Worth Unites at PurpleStride Kickoff
The saying, “Everything’s bigger in Texas,” holds true for our passionate pancreatic cancer community in Dallas-Fort Worth (DFW). Earlier today, […]
READ MORE
Deviant Immune Cells Incite Pancreatic Cancer
An all-star collaboration between three Pancreatic Cancer Action Network research grant recipients, representing three different institutions, has shown that immune […]
READ MORE
Studying How a New Immunotherapy Works in Each Patient
Thanks to the generosity of donors, we awarded our largest-ever grant of $2 million in 2016 to accelerate a large-scale […]
READ MORE
Rare but Targetable Genetic Change Discovered in Pancreatic Cancer Patients
The Pancreatic Cancer Action Network’s state-of-the-art Know Your Tumor® precision medicine service offers molecular profiling to eligible patients. Molecular profiling […]
READ MORE
“One-Two Punch” Combination Therapy
May is National Cancer Research Month! For National Cancer Research Month, we are highlighting some fantastic research advancements your support […]
READ MORE
The Pancreatic Cancer Mouse Model Used Today
May is National Cancer Research Month! For National Cancer Research Month, we are highlighting some fantastic research advancements your support […]
READ MORE
Grantee’s Discovery Validated by New Study Highlighting Strategy to Improve Drug Delivery
A novel peptide (small piece of protein) developed by a Pancreatic Cancer Action Network grantee was shown to benefit a […]
READ MORE
Pancreatic Cancer Highlighted at Record-breaking Scientific Conference
Last week, nearly 22,000 cancer researchers from around the world gathered in Washington, D.C., for the largest-ever American Association for […]
READ MORE
A New Strategy to Allow Immune Attack of Pancreatic Tumors
The more researchers analyze the interaction between pancreatic cancer cells and the patient’s immune system, the more complex the relationship […]
READ MORE
Celebrating New Research Grantees at International Meeting
Grantees and scientific leadership celebrating at awards dinner On the evening of Tuesday, April 4, the Pancreatic Cancer Action Network (PanCAN), […]
READ MORE
Smoking Increases Risk of Developing, Dying from Pancreatic Cancer
As a risk factor, smoking is thought to contribute to about 20 percent of pancreatic cancer cases. Now, new research […]
READ MORE
Volunteers, Researchers Connect During Chapel Hill Lab Visit
On a recent Saturday morning, the Der and Cox labs at the University of North Carolina at Chapel Hill were […]
READ MORE
Our Grantees Featured at Major International Cancer Research Conference
What would you do with $1 million to improve outcomes for pancreatic cancer patients? A diverse group of seven research […]
READ MORE
Critical Benchmarks Defined for Pancreatic Cancer Research Progress
It’s not every day that more than 450 pancreatic cancer researchers get together to talk about key topics in the […]
READ MORE
Prestigious promotion for member of our research community
We are delighted to report that our grantee, Brian Wolpin, MD, MPH, has been appointed Robert T. and Judith B. […]
READ MORE
Running Away from Home: Grantee Explores What Makes Pancreatic Cancer Cells Spread
Changes that cause a normal cell to become cancerous are often genetic in nature – mutations or altered expression of […]
READ MORE
Grantees Use Two-part Attack to Outsmart Pancreatic Cancer Cells
Researchers and clinicians have spent decades trying to devise ways to stop the growth and aggressive properties of pancreatic cancer […]
READ MORE
Oral Bacteria Linked to Pancreatic Cancer Risk in Grantee Study
In April 2016, Jiyoung Ahn, PhD, recipient of the 2012 The Daniel and Janet Mordecai – Career Development Award, presented […]
READ MORE
Annual Scientific Meeting Brings Together and Strengthens our Community for Progress
Our Annual Scientific Meeting took place August 18 – 21 in beautiful San Diego, bringing together research grant recipients, current […]
READ MORE
Research Team’s $1 Million Grant Funds Efforts toward Earlier Detection of Pancreatic Cancer
One of the reasons that pancreatic cancer is particularly challenging to clinicians is that the majority of cases are diagnosed […]
READ MORE
Grantee’s Preclinical Immunotherapy Data Shows Promise
Pancreatic cancer recently moved from the fourth to the third leading cause of cancer-related death in the United States, and […]
READ MORE
American Association for Cancer Research Pancreatic Cancer Special Conference Kicks Off with Nearly 450 Attendees
On Thursday evening, May 12, the American Association for Cancer Research (AACR) Pancreatic Cancer Special Conference kicked off in beautiful […]
READ MORE
American Association for Cancer Research Annual Meeting Convenes our Community for Progress
From April 16 to April 20, nearly 20,000 cancer researchers from around the world gathered in New Orleans for the […]
READ MORE
Grant Recipient and His Collaborative Team Identify Cells that Can Give Rise to Pancreatic Cancer
In an insightful study published in the major journal Cell Stem Cell, Timothy Wang, MD, together with his colleagues and […]
READ MORE
Grantee’s Findings About Pancreatic Cancer Cell Death Could Impact Future Treatments
The discovery of a new mode of pancreatic cancer cell death may play an important role in cancer cells’ survival.
Grantee’s Early-Phase Immunotherapy Clinical Trial Shows Encouraging Results
Preliminary results from an early-phase immunotherapy clinical trial suggest that an innovative treatment could be effective for patients with locally-advanced or borderline-resectable pancreatic cancer.
